Abstract
Purpose
Vitamin D is a relatively inexpensive drug yet an important hormone in terms of calcium and bone homeostasis. Treatment with vitamin D is associated with reduced fracture risk particularly in an elderly population. Therefore, we assessed the budgetary impact of routine prescription of 800 IU daily colecalciferol on hip fracture among older adults in the United Kingdom.
Methods
Using meta-analysis findings for treatment effect and UK-estimates of incidence, we performed a health economic evaluation of treating the UK population aged 65 and over with 800 IU of vitamin D daily, assessing the impact upon hip fracture costs using incremental attributable costs and excess mortality for a range of age- gender-based treatment strategies.
Results
Using only a 1-year horizon, considering only reduction in hip fracture, prescribing colecalciferol 800 IU daily to all adults aged 65 and over, could reduce the number of incident hip fractures from 65,400 to 45,700, saving almost 1,700 associated deaths, whilst saving the UK taxpayer £22 million.
Conclusions
As the UK government seeks to reduce public expenditure in all sectors, investment in prescribed prophylactic colecalciferol 800 IU therapy for adults aged 65 and over is likely to yield cost savings through reduction hip fracture alone in the first year.
Similar content being viewed by others
References
Mellanby E (1976) Nutrition Classics. The Lancet 1:407-12, 1919. An experimental investigation of rickets. Edward Mellanby. Nutr Rev 34:338–340
Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88:491S–499S
Darling AL, Hart KH, Macdonald HM et al (2013) Vitamin D deficiency in UK South Asian Women of childbearing age: a comparative longitudinal investigation with UK Caucasian women. Osteoporos Int 24:477–488
Hyppönen E, Power C (2007) Hypovitaminosis D in British adults at age 45 year: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85:860–868
Schöttker B, Haug U, Schomburg L et al (2013) Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr 25:782–793
Pearce SH, Cheetham TD (2010) Diagnosis and management of vitamin D deficiency. BMJ 340:b5664
Lee HJ, Gong HS, Song CH et al (2013) Evaluation of vitamin D level and grip strength recovery in women with a distal radius fracture. J Hand Surg Am 38:519–525
Diamond T, Wong YK, Golombick T (2013) Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency. Osteoporos Int 24:1101–1105
Dhesi JK, Jackson SHD, Bearne LM et al (2004) Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33:589–595
Muir SW, Montero-Odasso M (2011) Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 59:2291–2300
Murad MH, Elamin KB, Abu Elnour NO et al (2011) Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2997–3006
Cameron ID, Gillespie LD, Robertson MC et al (2012) Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 12:CD005465
Bischoff-Ferrari HA, Willett WC, Orav EJ et al (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367:40–49
Davies SC, Jewell T, McBride M, et al. VITAMIN D–ADVICE ON SUPPLEMENTS FOR AT RISK GROUPS. London: Department of Health 2012. https://www.gov.uk/government/publications/vitamin-d-advice-on-supplements-for-at-risk-groups
Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB et al (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692
Office for National Statistics (2011) Mortality figures for United Kingdom. http://www.statistics.gov.uk/hub/population/deaths/mortality-rates. (Accessed 14 Apr 2013)
NHSBSA Prescription Services. Electronic Drug Tariff. http://www.ppa.org.uk/ppa/edt_intro.htm. (Accessed 14 Apr 2014)
Collins GS, Mallett S, Altman DG (2011) Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of Q fracture scores. BMJ 342:d3651
Baker NL, Cook MN, Arrighi HM et al (2011) Hip fracture risk and subsequent mortality among Alzheimer’s disease patients in the United Kingdom, 1988–2007. Age Ageing 40:49–54
Parrott S. The Economic Cost of Hip Fracture in the UK. York: 00. http://webarchive.nationalarchives.gov.uk/+/http://www.berr.gov.uk/files/file21463.pdf
HM Treasury (2012) 2012 GDP deflators.http://www.hm-treasury.gov.uk/data_gdp_index.htm. (Accessed 29 Mar 2013)
Nikitovic M, Wodchis WP, Krahn MD et al (2013) Direct health-care costs attributed to hip fractures among seniors: a matched cohort study. Osteoporos Int 24:659–669
XE.com (2013) XE currency conversion. http://www.xe.com/ucc/convert/?Amount=37575&From=CAD&To=GBP. (Accessed 14 Apr 2013)
Kanis JA, Oden A, Johnell O et al (2003) The components of excess mortality after hip fracture. Bone 32:468–473
Office for National Statistics (2012) Death Registrations Summary Tables–England and Wales, 2011 (Final). http://www.ons.gov.uk/ons/rel/vsob1/death-reg-sum-tables/2011-final-/index.html. (Accessed 14 May 2013)
Woolf AD, Akesson K (2003) Preventing fractures in elderly people. BMJ 327:89–95
MHRA. Off-label or unlicensed use of medicines: prescribers’ responsibilities. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087990. (Accessed 14 Apr 2013)
Leblanc ES, Perrin N, Johnson JD et al (2013) Over-the-counter and compounded vitamin D: is potency what we expect? JAMA Intern Med 173:585–586
Garg S, Sabri D, Kanji J et al (2013) Evaluation of vitamin D medicines and dietary supplements and the physicochemical analysis of selected formulations. J Nutr Health Aging 17:158–161
British Orthopaedic Association (2007) The care of patients with fragility fracture. http://www.bgs.org.uk/pdf_cms/pubs/Blue%20Book%20on%20fragility%20fracture%20care.pdf. Accessed 14 Apr 2014
Bebbington A, Darton R, Netten A. Elderly people admitted to residential and nursing homes: 42 months on 2000. http://www.pssru.ac.uk/pdf/p051.pdf
Gutiérrez L, Roskell N, Castellsague J et al (2012) Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom. Bone 51:324–331
Holt G, Smith R, Duncan K et al (2008) Epidemiology and outcome after hip fracture in the under 65 s-evidence from the Scottish hip fracture audit. Injury 39:1175–1181
Gunasekera N, Boulton C, Morris C et al (2010) Hip fracture audit: the Nottingham experience. Osteoporos Int 21:S647–S653
Autier P, Gandini S (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167:1730–1737
Bjelakovic G, Gluud LL, Nikolova D et al (2011) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 7:CD007470
Grey A, Bolland M, Reid I (2012) Vitamin D dose requirements for fracture prevention. N Engl J Med 367:1367–1370
Gibson S (2001) Dietary sugars and micronutrient dilution in normal adults aged 65 years and over. Public Health Nutr 4:1235–1244
Bolland MJ, Grey A, Avenell A et al (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040
British Medical Association, Royal Pharmaceutical Society (2013) British National Formulary. 65th edn. BMJ Publishing & Pharmaceutical Press 2013. http://www.bnf.org
Conflict of interest
Dr Poole has previously consulted for Internis Pharmaceuticals (manufacturer of Fultium-D3), Astellas and Norgine. Dr Davies is a medical advisor to Internis Pharmaceuticals and has undertaken consultancy work for Meda (Manufacturer of Desunin) and Prostrakan (manufacturers of Adcal-D3). Dr Smith has nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Poole, C.D., Smith, J.C. & Davies, J.S. The short-term impact of vitamin D-based hip fracture prevention in older adults in the United Kingdom. J Endocrinol Invest 37, 811–817 (2014). https://doi.org/10.1007/s40618-014-0109-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-014-0109-2